Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Schiro, Andrew ^a,b   Wilkinson, Fiona L ^c   Weston, Ria ^c   Smyth, J Vincent ^a   Serracino Inglott, Ferdinand ^a,b,c   Alexander, M Yvonne ^b,c  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CLEC11A PROTEIN, HUMAN; CXCL9 CHEMOKINE; CYTOKINE; INTERLEUKIN 3; LECTIN; OSTEOCALCIN; OSTEOPONTIN; OSTEOPROTEGERIN;

AGED; BLOOD; CAROTID ENDARTERECTOMY; CAROTID STENOSIS; ENDOTHELIUM CELL; FEMALE; HUMAN; MALE; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAROTID STENOSIS; CELL-DERIVED MICROPARTICLES; CHEMOKINE CXCL9; CYTOKINES; ENDARTERECTOMY, CAROTID; ENDOTHELIAL CELLS; FEMALE; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; INFLAMMATION MEDIATORS; LECTINS, C-TYPE; MALE; MIDDLE AGED; OSTEOCALCIN; OSTEOPONTIN; OSTEOPROTEGERIN;

EID: 84946925523     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16658     Document Type: Article

References (34)

1. Rudarakanchana, N. et al. Current practice of carotid endarterectomy in the UK. Br J Surg 99, 209-216 (2012).
2. National Institute of Neurological Disorders and Stroke; Questions and Answers About Carotid Endarterectomy. 'http://www.ninds.nih.gov/disorders/stroke/carotid-endarterectomy-backgrounder.htm', (2012), (Date of access:07/05/2012).
3. Choi, J. C., Johnston, S. C. & Kim, A. S. Early outcomes after carotid artery stenting compared with endarterectomy for asymptomatic carotid stenosis. Stroke 46, 120-125 (2015).
4. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 273, 1421-1428 (1995).
5. Halliday, A. et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 376, 1074-1084 (2010).
6. Redgrave, J. N., Lovett, J. K., Gallagher, P. J. & Rothwell, P. M. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 113, 2320-2328 (2006).
7. Malaud, E. et al. Local carotid atherosclerotic plaque proteins for the identification of circulating biomarkers in coronary patients. Atherosclerosis 233, 551-558 (2014).
8. Tomey, M. I., Narula, J. & Kovacic, J. C. Advances in the understanding of plaque composition and treatment options: year in review. J Am Coll Cardiol 63, 1604-1616 (2014).
9. Ait-Oufella, H., Taleb, S., Mallat, Z. & Tedgui, A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 31, 969-979 (2011).
10. Schiro, A. et al. Endothelial microparticles as conveyors of information in atherosclerotic disease. Atherosclerosis 234, 295-302 (2014).
11. Lacroix, R. & Dignat-George, F. Microparticles: new protagonists in pericellular and intravascular proteolysis. Semin Thromb Hemost 39, 33-39 (2013).
12. Dalli, J. et al. Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties. Mol Cell Proteomics 12, 2205-2219 (2013).
13. Mause, S. F. & Weber, C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107, 1047-1057 (2010).
14. Bassiouny, H. S. et al. Critical carotid stenoses: morphologic and chemical similarity between symptomatic and asymptomatic plaques. J Vasc Surg 9, 202-212 (1989).
15. Chatzizisis, Y. S. et al. Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothelial shear stress colocalize with coronary atheromata with thin fibrous caps in pigs. Circulation 123, 621-630 (2011).
16. Shindo, A. et al. Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability. PLoS One 9, e100045 (2014).
17. Alexander, M. Y. et al. Identification and characterization of vascular calcification-associated factor, a novel gene upregulated during vascular calcification in vitro and in vivo. Arterioscler Thromb Vasc Biol 25, 1851-1857 (2005).
18. Wilkinson, F. L. et al. Contribution of VCAF-positive cells to neovascularization and calcification in atherosclerotic plaque development. The Journal of pathology 211, 362-369 (2007).
19. Leroyer, A. S. et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 49, 772-777 (2007).
20. Lanzino, G., Couture, D., Andreoli, A., Guterman, L. R. & Hopkins, L. N. Carotid endarterectomy: can we select surgical candidates at high risk for stroke and low risk for perioperative complications? Neurosurgery 49, 913-923; discussion 923-914 (2001).
21. Viera, A. J., Mooberry, M. & Key, N. S. Microparticles in cardiovascular disease pathophysiology and outcomes. J Am Soc Hypertens 6, 243-252 (2012).
22. Ueba, T. et al. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men. J Atheroscler Thromb 17, 342-349 (2010).
23. Wekesa, A. L. et al. Predicting carotid artery disease and plaque instability from cell-derived microparticles. EJVES 48, 489-495 (2014).
24. Sarlon-Bartoli, G. et al. Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. J Am Coll Cardiol 62, 1436-1441 (2013).
25. Suades, R., Padró, T., Alonso, R., Mata, P. & Badimon, L. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. Thromb Haemost 110, 366-377 (2013).
26. Wirtz, T. H. et al. Platelet-derived MIF: A novel platelet chemokine with distinct recruitment properties. Atherosclerosis 239, 1-10 (2015).
27. Chowdhury, M. et al. A comparative study of carotid atherosclerotic plaque microvessel density and angiogenic growth factor expression in symptomatic versus asymptomatic patients. Eur J Vasc Endovasc Surg 39, 388-395 (2010).
28. Yu, H. T. et al. Serum monokine induced by gamma interferon as a novel biomarker for coronary artery calcification in humans. Coron Artery Dis, 26, 317-321 (2015).
29. Fisman, E. Z., Motro, M. & Tenenbaum, A. Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol 2, 11, (2003).
30. Newby, A. C. Proteinases and plaque rupture: unblocking the road to translation. Curr Opin Lipidol 25, 358-366 (2014).
31. Platt, M. O. et al. Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis. Am J Physiol Heart Circ Physiol 292, H1479-1486 (2007).
32. Lutgens, E. et al. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113, 98-107 (2006).
33. Mandelin, J. et al. Human osteoblasts produce cathepsin K. Bone 38, 769-777 (2006).
34. Parker, B. et al. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus. Ann Rheum Dis 73, 1144-1150 (2013).